SCHEMBL30003554

SCHEMBL30003554

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAGI3 Q5TCQ9 1/20 0.61
▸ CASP1 P29466 1/20 0.57
▸ CASP3 P42574 1/20 0.57
▸ CASP4 P49662 1/20 0.57
▸ CASP5 P51878 1/20 0.57
▸ CASP7 P55210 1/20 0.57
▸ CASP9 P55211 1/20 0.57
▸ CASP6 P55212 1/20 0.57
▸ CASP8 Q14790 1/20 0.57
▸ CASP10 Q92851 1/20 0.57
▸ GHSR Q92847 3/20 0.53
▸ ERBB2 P04626 1/20 0.53
▸ KISS1R Q969F8 5/20 0.52
▸ CCKBR P32239 7/20 0.52
▸ CCKAR P32238 1/20 0.52
▸ EDNRA P25101 1/20 0.49
▸ IL23R Q5VWK5 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11151034 0.92 MAGI3 (0.57) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL11151039 0.92 MAGI3 (0.57) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL29386744 0.88 MAGI3 (0.55) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL38664666 0.88 MAGI3 (0.57) MAGI3GHSRCCKBRCCKAREDNRA
SCHEMBL30051105 0.87 ACE (0.56) MAGI3EDNRA
SCHEMBL30000396 0.83 MAGI3 (0.64) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL30503364 0.83 MAGI3 (0.60) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL31483375 0.83 GHSR (0.64) GHSRKISS1R
SCHEMBL25549782 0.83 GHSR (0.59) MAGI3CASP1CASP3CASP4CASP5
SCHEMBL30010641 0.82 ACE (0.60) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12186408-B2 Fusion polypeptides for inhibiting angiogenesis, fusion protein nanocages having multivalent peptides for inhibiting angiogenesis, and theranostic use thereof INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) 2025-01-07 — — US disclosed
US-11518798-B2 Vascular endothelial growth factor receptor targeting peptide-elastin fusion polypeptides INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) 2022-12-06 — — US disclosed
US-20220331453-A1 FUSION POLYPEPTIDES FOR INHIBITING ANGIOGENESIS, FUSION PROTEIN NANOCAGES HAVING MULTIVALENT PEPTIDES FOR INHIBITING ANGIOGENESIS, AND THERANOSTIC USE THEREOF INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) 2022-10-20 — — US disclosed
Send feedback